Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas

NCT04656730 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome
Functional Dyspepsia

Interventions

DRUG: Iberogast® and Iberogast® N

Sponsor

Hospital Vall d'Hebron

Collaborators

[object Object]